Volume 11, Number 9—September 2005
Research
Dengue Virus Type 3, Brazil, 2002
Table 1
Month | Virus isolation positive/studied (%) | RT-PCR positive/studied (%) | Serotype detected | MAC-ELISA positive/studied (%) | IgG-ELISA positive/studied (%) | Confirmed cases/studied cases (%) | Deaths positive/studied (%) |
---|---|---|---|---|---|---|---|
January | 114/360 | 47/93 | 2 DENV-1; 1 DENV-2; 135 DENV-3 | 203/373 | 61/67 | 308/525 | 6/8 |
February | 61/315 | 49/89 | 103 DENV-3 | 212/356 | 29/41 | 279/504 | 15/20 |
March | 55/173 | 28/69 | 72 DENV-3 | 123/220 | 15/29 | 187/375 | 15/23 |
April | 3/45 | 5/18 | 7 DENV-3 | 38/71 | 3/8 | 49/97 | 4/8 |
May | 2/22 | 0/7 | 2 DENV-3 | 4/26 | ND | 6/38 | 0/1 |
June | 2/6 | 0/6 | 2 DENV-3 | 0/9 | 0/2 | 2/11 | 0/2 |
July | 0/6 | ND | 0 | 0/5 | 0/1 | 0/9 | 0 |
Total | 237/927 (25.6) | 129/282 (45.7) | 2 DENV-1; 1 DENV-2; 321 DENV-3 | 580/1,060 (54.7) | 108/148 (73.0) | 831/1,559 (53.3) | 40/62 (64.5) |
*RT-PCR, reverse transcriptase–polymerase chain reaction; MAC-ELISA, immunoglobulin M antigen capture enzyme-linked immunosorbent assay; IgG, immunoglobulin G; DENV, dengue virus; ND, not done.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.